Literature DB >> 33345853

Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz. (Baill.), a current review.

Yuan Zhou1, Lihui Men2, Yunxia Sun3, Mengying Wei4, Xiang Fan5.   

Abstract

Fruit of Schisandra chinensis Turcz. (Baill.) (S. chinensis) is a traditional herbal medicine widely used in China, Korea, and many other east Asian countries. At present, S. chinensis commonly forms Chinese medicinal formulae with other herbal medicines to treat liver disease and neurological disease in clinical. Modern researches indicated that lignans were the main active ingredients of S. chinensis with high content and novel dibenzocyclooctadiene skeletal structure, exhibited considerable antioxidant, anti-inflammatory, and neuroprotective properties. Additionally, some of these lignans also showed certain potentials in anti-cancer, anti-fibrosis, and other effects. In the current review, we summarize literature reported lignans from S. chinensis in the past five years, and highlight the molecular mechanisms of lignans in exerting their biological functions. Also, we point out some deficiencies of existing researches and discuss the future direction of lignans study.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammation; Antioxidation; Lignans; Neuroprotection; S. chinensis

Mesh:

Substances:

Year:  2020        PMID: 33345853     DOI: 10.1016/j.ejphar.2020.173796

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke.

Authors:  Meiying Song; Yuan Zhou; Xiang Fan
Journal:  Mol Neurobiol       Date:  2022-03-09       Impact factor: 5.590

Review 2.  Polyphenols for the Treatment of Ischemic Stroke: New Applications and Insights.

Authors:  Shuhan Liu; Feng Lin; Jian Wang; Xiaoqiang Pan; Liguang Sun; Wei Wu
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

3.  Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats.

Authors:  Yuan Zhou; Ruoqi Li; Yingyi Zheng; Meiying Song; Shanshan Zhang; Yunxia Sun; Mengying Wei; Xiang Fan
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

4.  Schisandrin B Induced ROS-Mediated Autophagy and Th1/Th2 Imbalance via Selenoproteins in Hepa1-6 Cells.

Authors:  Siran Tan; Zhi Zheng; Tianqi Liu; Xiaoyun Yao; Miao Yu; Yubin Ji
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 8.786

Review 5.  Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury.

Authors:  Tianwen Yao; Wenxiang Su; Shisheng Han; Yan Lu; Yanqiu Xu; Min Chen; Yi Wang
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 6.  Research Progress on the Pharmacological Action of Schisantherin A.

Authors:  Zehao Xiao; Wen Xiao; Guilin Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-12       Impact factor: 2.629

7.  Schisandra rubriflora Fruit and Leaves as Promising New Materials of High Biological Potential: Lignan Profiling and Effect-Directed Analysis.

Authors:  Ewelina Sobstyl; Agnieszka Szopa; Michał Dziurka; Halina Ekiert; Hanna Nikolaichuk; Irena Maria Choma
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

8.  Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis.

Authors:  Seong Jae Han; Jimoon Jun; Seong-Il Eyun; Choong-Gu Lee; Jimin Jeon; Cheol-Ho Pan
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08

Review 9.  Role of Polyphenols as Antioxidant Supplementation in Ischemic Stroke.

Authors:  Yuan Zhou; Shanshan Zhang; Xiang Fan
Journal:  Oxid Med Cell Longev       Date:  2021-06-25       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.